BARCLAYS PLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 70 filers reported holding IMMUNE DESIGN CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$136,000
+3300.0%
23,314
+689.8%
0.00%
Q4 2018$4,000
-91.8%
2,952
-78.9%
0.00%
Q3 2018$49,000
+308.3%
13,999
+467.2%
0.00%
Q2 2018$12,000
-45.5%
2,468
-63.1%
0.00%
Q1 2018$22,000
+10.0%
6,685
+31.5%
0.00%
Q4 2017$20,000
-84.3%
5,083
-58.7%
0.00%
Q3 2017$127,00012,296
+102366.7%
0.00%
Q2 2017$0
-100.0%
12
-97.8%
0.00%
Q1 2017$3,000
-94.1%
546
-94.0%
0.00%
Q4 2016$51,000
+5000.0%
9,158
+5287.1%
0.00%
Q3 2016$1,000
-50.0%
170
-35.6%
0.00%
Q2 2016$2,000
+100.0%
264
+288.2%
0.00%
Q1 2016$1,000
-83.3%
68
-78.3%
0.00%
Q4 2015$6,000
+500.0%
314
+423.3%
0.00%
Q3 2015$1,000
-75.0%
60
-72.1%
0.00%
Q2 2015$4,0000.0%215
+17.5%
0.00%
Q1 2015$4,000
-63.6%
183
-47.3%
0.00%
Q4 2014$11,0003470.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q1 2019
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,962,720$16,016,0006.52%
Abingworth LLP 197,300$1,610,0001.69%
NEXTHERA CAPITAL LP 85,138$695,0000.60%
Cormorant Asset Management, LP 432,990$3,533,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 153,000$1,248,0000.32%
TFS CAPITAL LLC 102,685$838,0000.15%
RS INVESTMENT MANAGEMENT CO LLC 1,227,595$10,017,0000.10%
Eventide Asset Management 180,000$1,469,0000.09%
Focused Wealth Management, Inc 15,868$129,0000.06%
Spark Investment Management LLC 77,500$632,0000.06%
View complete list of IMMUNE DESIGN CORP shareholders